Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fe3 Medical is a medical technology company that developed a novel transdermal patch for the treatment of iron deficiency anemia (IDA). A spin-off from InCube Labs, the company utilized iontophoresis technology to deliver iron ions through the skin and directly into the bloodstream. This method was designed to bypass the gastrointestinal tract, thereby eliminating the severe gastric side effects often associated with oral iron supplements while avoiding the complexity of intravenous infusions. The company's lead program successfully completed a Phase 1/2a clinical study, demonstrating controlled delivery of iron with a favorable safety profile. Despite promising early clinical results, the company has been inactive in recent years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fe3 Medical.